Home Duke University Press
 QUICK SEARCH:   [advanced]


     
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Neuro Oncol 2002 4(3):179-186; DOI:10.1215/15228517-4-3-179
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuriyama, H.
Right arrow Articles by Israel, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Duke University Press

Medical Neuro-Oncology

Prognostic significance of an apoptotic index and apoptosis/proliferation ratio for patients with high-grade astrocytomas

Hiroko Kuriyama, Kathleen R. Lamborn, Judith R. O'Fallon, N. Iturria, Thomas Sebo, Paul L. Schaefer, Bernd W. Scheithauer, Jan C. Buckner, Nagato Kuriyama, Robert B. Jenkins and Mark A. Israel2

The Preuss Laboratory for Molecular Neuro-Oncology, Brain Tumor Research Center (H.K., N.K., M.A.I.); Department of Neurological Surgery, University of California, San Francisco, CA 94143 (H.K., K.R.L., N.K., M.A.I.); Mayo Clinic and Foundation, Rochester, MN 55905 (J.R.O., N.I., T.S., B.W.S., J.C.B., R.B.J.); Toledo Community Hospital Oncology Program, Toledo, OH 43623 (P.L.S.)

2 Address correspondence and reprint requests to Mark A. Israel, Norris Cotton Cancer Center, Dartmouth Medical School, Dartmouth-Hitchcock Medical Center, 1 Medical Center Dr., Lebanon, NH 03756.

Abstract

We evaluated the association of spontaneous apoptosis and an apoptosis/proliferation index with survival to determine the potential of such measures to serve as predictive markers for patients with glioblastoma multiforme (GBM). We examined the extent of spontaneous apoptosis in tumors from newly diagnosed patients, 75 with GBM and 21 with anaplastic astrocytoma, who were entered on treatment protocols of the North Central Cancer Treatment Group. In the group of GBM patients, those with a higher apoptotic index tended to live longer (P = 0.04; Cox proportional hazards model including performance score, age, and extent of resection in a multivariate model). We found that the apoptotic index values for anaplastic astrocytoma patients tended to be lower than those in the GBM patients, although with small sample sizes, the result was not statistically significant (P = 0.1). We also examined expression of the Ki-67 cell proliferation antigen immunohistochemically using the MIB-1 monoclonal antibody. Ki-67 expression did not provide additional information regarding the survival of patients with GBM. In this group of GBM patients, those patients with higher apoptotic index/proliferation ratios had a better prognosis than did those with a low ratio (P < 0.021, same model as above). These findings suggest that both apoptosis and a cell death/cell proliferation ratio are associated with patient survival, and they may be useful for either the clinical evaluation of patients with GBM or the stratification of patients for treatment evaluation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
K. Heon Seo, H.-M. Ko, H.-A Kim, J.-H. Choi, S. Jun Park, K.-J. Kim, H.-K. Lee, and S.-Y. Im
Platelet-Activating Factor Induces Up-regulation of Antiapoptotic Factors in a Melanoma Cell Line through Nuclear Factor-{kappa}B Activation.
Cancer Res., May 1, 2006; 66(9): 4681 - 4686.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Q. Shi, S. Bao, J. A. Maxwell, E. D. Reese, H. S. Friedman, D. D. Bigner, X.-F. Wang, and J. N. Rich
Secreted Protein Acidic, Rich in Cysteine (SPARC), Mediates Cellular Survival of Gliomas through AKT Activation
J. Biol. Chem., December 10, 2004; 279(50): 52200 - 52209.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
B. F. Porter, B. A. Summers, M. M. Leland, and G. B. Hubbard
Glioblastoma Multiforme in Three Baboons (Papio spp)
Vet. Pathol., July 1, 2004; 41(4): 424 - 428.
[Abstract] [Full Text] [PDF]




  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents


Copyright 2002 by Society for Neuro-Oncology